Losartan EP Impurity A | CAS 79047-41-9 - Request Quote
Losartan EP Impurity A
| SZ CAT No: | SZ-L028002 |
| CAS No | 79047-41-9 |
| Mol.F. | C8H13ClN2O |
| Mol.Wt. | 188.7 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Losartan EP Impurity A is chemically 2-Butyl-4-chloro-1H-imidazole-5-methanol . Losartan EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Losartan EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Losartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 79047-41-9
Purchase 79047-41-9
Order 79047-41-9
Enquire 79047-41-9
price of 79047-41-9
79047-41-9 Supplier
79047-41-9 Manufacturer
79047-41-9 Exporter
buy high quality Losartan EP Impurity A
Purchase Losartan EP Impurity A
Losartan EP Impurity A suppliers
Losartan EP Impurity A manufacturers
Losartan EP Impurity A price
Order Losartan EP Impurity A
Enquire Losartan EP Impurity A
Losartan EP Impurity A cost
Losartan EP Impurity A Supplier
Losartan EP Impurity A Distributor
Losartan EP Impurity A for Method Validation
Losartan Reference Standard
Losartan EP Impurity A for ANDA Filing
Losartan EP Impurity A for Forced Degradation Studies
Losartan EP Impurity A Identification Standards
Losartan EP Impurity A for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.